A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Although reports of vision problems with weight loss drugs are still rare, researchers say there is cause for concern because of how widespread the medications are becoming. A 2024 study found that 12 percent of the U.S. has taken one of these drugs and 6 percent are currently taking them.

A recent study suggests a potential link between Ozempic and vision loss, particularly non-arteritic anterior ischemic optic neuropathy (NAION), raising concerns about rapid blood sugar reduction affecting eye health.